Sagent Pharmaceuticals, a Nichi-Iko Group company, and provider of specialty pharmaceutical products with an emphasis on the injectable market, has acquired an FDA-approved manufacturing site in Raleigh, NC from Xellia Pharmaceuticals.   The manufacturing site, which is approved for manufacturing of both small molecule and biologic products, is the first FDA-approved facility in the Nichi-Iko Group network. Sagent intends to continue manufacturing certain products for Xellia, while utilizing the...